Researchers have uncovered what makes one particular strain of methicillin-resistant Staphylococcus aureus (MRSA) so proficient at picking up resistance genes, such as the one that makes it resistant to vancomycin, the last line of defense for hospital-acquired infections.

Methicillin-resistant Staphylococcus (MRSA) nasal colonization is associated with longer hospital stays and an increase in surgical site infections (SSI) in patients undergoing major gastrointestinal surgery.

National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) epidemics in most of Asia.

WAYNE, Pa., April 16, 2012 /PRNewswire/ -- Molecular Detection Inc.

NEW YORK, April 10, 2012 /PRNewswire/ -- MRSA--the super virulent bacteria that is a leading cause of infections during patient hospitalization--has met its match: Antimicrobial Copper.